||Registry of biomedical companies:
   [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 592 active entries
Phone: +49 30 9489 2201
Fax: +49 30 9489 3201
emp Biotech GmbH is a limited liability company founded in Germany in 1993. Dr. Derek Levison, the managing director since 1995 and Dr. Uwe Möller, principle scientist, are both organic chemists with expertise in fluorescent dye chemistry and synthetic modification of proteins and nucleotides. emp Biotech, in cooperation with Princeton Separations, has been developing since 1997 its proprietary solid-state chemiluminescence technology. A spin-off immunodiagnostics company was launched in 2005. emp Biotech's main technical focus is: • Synthesis of modified dyes and derivatives • Synthesis of labeled and modified nucleic acids • Synthesis and production of oligonucleotide modifying reagents (dyes, linkers, and haptens) • Synthesis of labeled and/or modified antibodies, enzymes and other proteins • Synthesis of modified biochemical components (haptens, linkers and substrates) • Manufacturing and packaging of reagents for DNA synthesis • Production of fluorescent dye labeling kits for proteins and oligonucleotides • Development of non-radioactive labeling and detection by means of fluorescent and chemiluminescent methods • Pilot-scale organic synthesis • Custom contract synthesis More information can be found at www.empbiotech.com
Last update of this entry: October 28, 2015
Bookmark and Share this page (what is this?)
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
Read more about social bookmarking at Wikipedia - Social Bookmarking